News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Vivek Podder: Our latest selected abstracts presented at SNO2024
Vivek Podder/LinkedIn
Nov 26, 2024, 19:36

Vivek Podder: Our latest selected abstracts presented at SNO2024

Vivek Podder, Research Fellow in Gynecological Oncology at Mount Sinai Medical Center of Florida, shared a post on LinkedIn:

“Elated to share our latest selected abstracts being presented at SNO2024 in Houston, TX! One of them includes an oral presentation by Manmeet Ahluwalia, MD, MBA, FASCO. These abstracts focus on advancing knowledge in brain metastases and oncology research.

Here are the abstracts:

‘CNSC-62. Differential survival impact of trastuzumab deruxtecan in HER2-positive versus HER2-low breast cancer patients with brain metastases’

Vivek Podder: Our latest selected abstracts presented at SNO2024

‘DISP-19. Ethnic disparities in metastasis patterns and treatment utilization among metastatic breast cancer patients with brain metastasis: A retrospective analysis of US health systems data (2019-2023)’

Vivek Podder: Our latest selected abstracts presented at SNO2024

‘BIOS-05. Peptide-based vaccines versus dendritic cell-based vaccine therapies for patients with glioblastoma: A network meta-analysis of controlled clinical trials’

Vivek Podder: Our latest selected abstracts presented at SNO2024

‘EPID-18. Patterns of care and clinical outcomes of patients with glioblastoma from 2005-2020: A real-world analysis’

Vivek Podder: Our latest selected abstracts presented at SNO2024

Excited to contribute to the growing body of research in brain metastases and to engage in meaningful discussions at SNO2024!”

For more posts like this, visit oncodaily.com.

cancer Manmeet Ahluwalia OncoDaily Oncology SNO2024 Vivek Podder
Special Coverage
Blog
Dec 22, 2024, 18:02
Erman Akkus: Negative hyper-selection for anti-EGFR therapy in mCRC
Insight
Dec 22, 2024, 17:57
Gustavo Viani: Internal Mammary Node Radiation, A Survival Boost for Breast Cancer Patients?
Insight
Dec 22, 2024, 17:54
Stephen Liu: The seminal IPASS trial in EGFR NSCLC
Insight
Dec 22, 2024, 17:51
Angela Lamarca: eUpdate of ESMO Biliary Malignancies CP Guidelines
Insight
Dec 22, 2024, 17:47
Next-gen immunotherapy is reshaping lung cancer treatment
Insight
Dec 22, 2024, 17:44
Erman Akkus: Local treatments of HCC, 2 recent studies
Blog
Dec 22, 2024, 17:39
Mark Cobbold: Incredible Year in Cell Therapy and Immunotherapy at AstraZeneca
Insight
Dec 22, 2024, 17:36
Nicholas Hornstein: Something new in BRAF V600E mCRC
Insight
Dec 22, 2024, 17:32
Fawzi Abu Rous: We launched Lung Cancer Alliance in Arabic-Speaking MENA
Science
Dec 22, 2024, 17:26
Andrea De Giglio: The prognostic role of STK11 mutations in advanced NSCLC treated with first-line IO
Science
Dec 22, 2024, 17:23
Zeynep Irem Ozay: Assessing nectin-4 as a predictive biomarker in GU malignancies
Science
Dec 22, 2024, 17:18
Sam Klempner: Proof of principle in KRAS G12C mutation in colorectal cancer